UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. ________)*


IntelliCell BioSciences, Inc.
(Name of Issuer)

Common Stock
(Title of Class of Securities)


45825A105
(CUSIP Number)


July 25, 2014
(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[_] Rule 13d-1(b)
[x] Rule 13d-1(c)
[_] Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment containing
information which would alter the disclosures provided in a prior cover
page.

The information required in the remainder of this cover page shall not
be deemed to be ?filed? for the purpose of Section 18 of the
Securities Exchange Act of 1934 (?Act?) or otherwise subject to the
liabilities of that section of the Act but shall be subject to all
other provisions of the Act (however, see the Notes).

Persons who respond to the collection of information contained in this
form are not required to respond unless the form displays a currently
valid OMB control number.



13G
CUSIP No.  45825A105

1.  Names of Reporting Persons.

  TIMOTHY RYAN MARSHALL
2.  Check the Appropriate Box if a Member of a Group
(a) [_]
(b) [_]
3.  SEC Use Only
4.  Citizenship or Place of Organization
  UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:
5.  Sole Voting Power
 147,535,166 COMMON STOCK

6.  Shared Voting Power
 0

7.  Sole Dispositive Power
 147,535,166 COMMON STOCK

8.  Shared Dispositive Power
 0
9.  Aggregate Amount Beneficially Owned by Each Reporting Person
 147,535,166 COMMON STOCK
10.  Check if the Aggregate Amount in Row (9) Excludes Certain Shares
[_]
11.  Percent of Class Represented by Amount in Row (9)
 6.26
12.  Type of Reporting Person
 IN



13G
CUSIP No.  45825A105

ITEM 1.
(a) Name of Issuer:
IntelliCell BioSciences, Inc.

(b) Address of Issuer's Principal Executive Offices:
460 Park Avenue, 17th Floor, New York, NY 10022

ITEM 2.
(a) Name of Person Filing:
Timothy Ryan Marshall

(b) Address of Principal Business Office, or if None, Residence:
3020 Calle de Marejada, Camarillo, CA 93010

(c) Citizenship:
United States

(d) Title of Class of Securities:
Common Stock

(e) CUSIP Number:
45825A105

ITEM 3.
IF THIS STATEMENT IS FILED PURSUANT TO SS.240.13d-1(b) OR
240.13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:


(a)
[_]
Broker or dealer registered under Section 15 of the Act  (15 U.S.C. 78o).

(b)
[_]
Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).

(c)
[_]
Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).

(d)
[_]
Investment company registered under Section 8 of the Investment Company Act
of 1940 (15 U.S.C. 80a-8).

(e)
[_]
An investment adviser in accordance with  ss.240.13d-1(b)(1)(ii)(E);

(f)
[_]
An employee benefit plan or endowment fund in accordance with
ss.240.13d-1(b)(1)(ii)(F);

(g)
[_]
A parent holding company or control person in accordance with
ss.240.13d-1(b)(1)(ii)(G);

(h)
[_]
A savings associations as defined in Section 3(b) of the Federal Deposit
Insurance Act (12 U.S.C. 1813);

(i)
[_]
A church plan that is excluded from the definition of an investment company
under section 3(c)(14) of the Investment Company Act of 1940
(15 U.S.C. 80a-3);

(j)
[_]
Group, in accordance with ss.240.13d-1(b)(1)(ii)(J).

ITEM 4. OWNERSHIP.

Provide the following information regarding the aggregate number and percentage
of the class of securities of the issuer identified in Item 1.

(a) Amount beneficially owned:
147,535,166 COMMON STOCK

(b) Percent of class:
6.26

(c) Number of shares as to which such person has:

(i)  Sole power to vote or to direct the vote:
147,535,166 COMMON STOCK

(ii) Shared power to vote or to direct the vote:
0

(iii) Sole power to dispose or to direct the disposition of:
147,535,166 COMMON STOCK

(iv) Shared power to dispose or to direct the disposition of:
0

INSTRUCTION. For computations regarding securities which represent a right
to acquire an underlying security SEE ss.240.13d3(d)(1).



ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.

If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more
than five percent of the class of securities, check the following [_].

INSTRUCTION: Dissolution of a group requires a response to this item.

ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
N/A

ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
N/A

ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
N/A

ITEM 9. NOTICE OF DISSOLUTION OF GROUP.
N/A


ITEM 10. CERTIFICATIONS.

By signing below I certify that, to the best of my knowledge and belief, the
securities referred to above were not acquired and are not held for the purpose
of or with the effect of changing or influencing the control of the issuer of
the securities and were not acquired and are not held in connection with or as
a participant in any transaction having such purpose or effect.



SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.


September 8, 2014
(Date)


/s/ Timothy Ryan Marshall
(Signature)


Timothy Ryan Marshall
(Name/Title)